Remecure ApS
CVR 40259724 · Private limited company (ApS) · Active · Low risk
Remecure ApS is a Private limited company (ApS), founded on , based in Holte. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 7 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 235k and a net result of DKK 5,453. CEO: Mohamed MAMDOUH Takach.
Bankruptcy risk for Remecure ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40259724
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (7 years)
- Address
- Dronninggårds Alle 69
2840 Holte - Municipality
- Rudersdal
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 2 of 7 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 13.0% |
| Current ratio | 115% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 8,950 | DKK -12k | DKK 298k |
| Net profit | DKK 5,453 | DKK -18k | DKK 238k |
| Equity | DKK 235k | DKK 229k | DKK 247k |
| Total assets | DKK 1.8m | DKK 988k | DKK 1.4m |
| Cash | DKK 512k | DKK 324k | – |
| Short-term debt | DKK 1.6m | DKK 759k | – |
| Tax owed | – | DKK 0 | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: No audit assistance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 180 | ||
| 1 Jan 2022 – 31 Dec 2022 | 177 | ||
| 1 Jan 2021 – 31 Dec 2021 | 181 | ||
| 1 Jan 2020 – 31 Dec 2020 | 188 | Late | |
| 12 Feb 2019 – 31 Dec 2019 | 234 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mohamed MAMDOUH Takach | Current | |
| Owner (50%) | Stephanie Cecilia Arnfeldt Castella | Current | |
| Owner (50%) | Mohamed MAMDOUH Takach | Current | |
| Founder | Stephanie Cecilia Arnfeldt Castella | Current | |
| Founder | Mohamed MAMDOUH Takach | Current |
Address history (0 moves)
| Dronninggårds Alle 69, 2840 Holte |
Former names
| Remecure ApS | – now |
| Remecure IVS | – |
Other companies at the same address
- CBK INVEST A/S Fusioneret
- Castella Care Holte ApS Active
- Ello Copenhagen IVS Opløst
- RAMAS INTERNATIONAL A/S Active
Similar companies in Rudersdal
- ALK-ABELLÓ A/S Hørsholm
- AleSac ApS Holte
- Breye Therapeutics ApS Hørsholm
- Allarity Therapeutics Denmark ApS Hørsholm
- Allarity Therapeutics Europe ApS Hørsholm
- SYNACT PHARMA ApS Holte
- SCANPHARM A/S Birkerød
- Højbo Healthcare ApS Vedbæk
- Bacthera Denmark A/S Hørsholm
- AddMe Consulting ApS Vedbæk
- Inpare ApS Hørsholm
Questions and answers about Remecure ApS
Has Remecure ApS gone bankrupt?
No, Remecure ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Remecure ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of Remecure ApS?
Mohamed MAMDOUH Takach is the CEO of Remecure ApS.
When was Remecure ApS founded?
Remecure ApS was founded on 12 February 2019.
What is the equity of Remecure ApS?
Equity was DKK 235k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.